Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetically linked brain imaging markers of memory decline in aging and Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Exercise and nutritional prehabilitation in gastrointestinal cancer patients: prospective controlled trial assessing feasibility, safety and effects on quality of life.

BMC cancer·2026

Same author

A multi-center cross-sectional study to explore cancer patients' views on facilitators and barriers for the implementation of oncological exercise therapy.

Frontiers in oncology·2026

Same author

Correction: Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy (OTT).

Sports medicine - open·2026

Same author

Status Quo analysis of an exercise therapy care model in pediatric oncology during acute therapy: perspectives from patients, parents, siblings, and staff.

Frontiers in pediatrics·2026

Same author

Interocular symmetry in dynamic retinal vessel analysis among healthy adults.

Biomolecules & biomedicine·2026

Search research articles

Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Innovative Exercise in Routine Cancer Care: Insights from Eight Years of Integrated Oncological Exercise Therapy

Timo Sonntag¹, Ariana Safi², Vera Coutellier²

¹Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. timo.niels@uk-koeln.de.

Sports Medicine - Open

|March 4, 2026

Summary

Structured oncological exercise therapy (OTT) shows benefits for cancer patients, improving physical performance and patient-reported outcomes. Strategies to increase exercise attendance are crucial for maximizing these positive effects in clinical settings.

Keywords:

Cancer patients Clinical care Exercise oncology Exercise program Neoplasms Physical activity

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Area of Science:

Oncology
Exercise Science
Rehabilitation Medicine

Background:

The positive impact of exercise on cancer patients is recognized, but integrating structured oncological exercise into standard care is challenging.
This study evaluates a supervised Oncological Exercise Therapy (OTT) program integrated into clinical care.

Purpose of the Study:

To assess patient characteristics, exercise participation, and the effects of OTT on patient-reported outcomes (PROs) and physical performance.
To determine the feasibility and efficacy of implementing OTT in a standard clinical setting.

Main Methods:

An observational study analyzed data from 1660 cancer patients enrolled in OTT between 2012 and 2020.
Patients were encouraged to attend personalized OTT for at least three months, with data collected on demographics, medical history, and treatment.
Exercise attendance was tracked for up to one year, and efficacy was assessed via strength/endurance tests and PROs (quality of life, fatigue, psychosocial distress) between 6 and 24 weeks.

Main Results:

The study included 1660 patients (median age 54, 70% female, 40% breast cancer, 80% without metastasis).
Only 32% exercised regularly (average 19 sessions over 19 weeks), with only 1% meeting the recommended ≥2 sessions/week.
Improved strength, endurance, and PROs were observed, with greater benefits correlating with higher exercise attendance. Older age and shorter travel distance were linked to better attendance.

Conclusions:

Innovative exercise programs like OTT can be integrated into standard hospital-based cancer care.
Real-world data confirm the beneficial effects of exercise on PROs and physical outcomes in cancer patients.
Enhancing exercise attendance is critical to fully realize the benefits of real-world exercise interventions for cancer patients.